✨
AI Summary
- Lilly explores Zepbound for autoimmune diseases, expanding its therapeutic reach.
- AstraZeneca focuses on interconnected strategy in cardiovascular risk management.
- GSK expands oncology portfolio by acquiring Nuvalent, signaling growth ambitions.